Dr. Fu’s research interests are primarily focused on pediatric cardiology, including congenital heart defects, pediatric cardiomyopathies, pediatric pulmonary arterial hypertension, and other rare cardiovascular diseases in children.

Shanghai Science and Technology Progress Award; Shanghai Pudong New Area Science and Technology Award; Huaxia Medical Science and Technology Award; Song Chingling Pediatric Medicine Award.

Cardiovascular Professional Committee of Pediatricians Branch of Chinese Medical Doctor Association; Pediatric Branch of Chinese Medical Association; Pediatric Specialty Branch of Shanghai Medical Association.

National Natural Science Foundation of China (81974029) : Mechanism of LZTR1 mutation-induced RAS/MAPK pathway hyperactivation and Noonan syndrome-associated hypertrophic cardiomyopathy；

National Natural Science Foundation of China (81770380) : The role of HIF-1 pathway in mediating LAMP2 deficiency-induced hypertrophic cardiomyopathy.

Ren H, Xie L, Wang Z, Tang X, Ning B, Teng T, Qian J, Wang Y, Fu L #, Zhao Z#, Xiang L#. Comparison of Global and Regional Compliance-Guided Positive End-Expiratory Pressure Titration on Regional Lung Ventilation in Moderate-to-Severe Pediatric Acute Respiratory Distress Syndrome. Front Med (Lausanne). 2022 May 23;9:805680. （IF 5.058，Q1）

Chan W, Yang S, Wang J, Tong S, Lin M, Lu P, Yao R, Wu L, Chen L, Guo Y, Shen J, Liu T, Li F, Chen H, Zhang H, Wang S,and Fu L #. Clinical Characteristics and Survival of Children with Hypertrophic Cardiomyopathy in China: A Multicentre Retrospective Cohort Study. eClinicalMedicine, 2022;49: 101466（IF 17.033，Q1）

Zhu D, Zhu J, Qiu W, Wang B, Liu L, Yu X, Ou Z, Shan G, Wang J, Liu C, Li Z, Fu L#. A multi-centre prospective study of the efficacy and safety of alglucosidase alfa in Chinese patients with infantile-onset Pompe disease. Front Pharmacol. 2022,13:903488. （IF 5.988，Q1）

Zhang Q, Ding Y, Feng B, Tang Y, Chen Y, Wang Y, Chang G, Liu S, Wang J, Li Q, Fu L#, Wang X#. Molecular and Phenotypic Expansion of Alström Syndrome in Chinese Patients. Front Genet. 2022;13:808919（IF 4.772，Q2）

Zhao QH, Wu WH, Fu LJ #, Wang L#. Adult-onset hypoxaemia, diffuse lung lesions, and pulmonary hypertension in cobalamin C defect: a case report. Eur Heart J Case Rep. 2021;5(6):ytab251.

Xiang L, Ren H, Wang Y, Zhang J, Qian J, Li B, An K, Fu L#. Clinical value of pediatric sepsis-induced coagulopathy score in diagnosis of sepsis-induced coagulopathy and prognosis in children. J Thromb Haemost. 2021;19(12):2930-2937. （IF 16.036，Q1）

Xiang L, Wang H, Fan S, Zhang W, Lu H, Dong B, Liu S, Chen Y, Wang Y#, Zhao L# and Fu L#. Machine Learning for Early Warning of Septic Shock in Children With Hematological Malignancies Accompanied by Fever or Neutropenia: A Single Center Retrospective Study. Front. Oncol,2021,11:678743. （IF 5.738，Q2）

Wu J, Lu Y, Zhao W, Shen J, Li F, Zhang H, Chen Q#, Fu L#. Clinical characteristics and therapeutic outcomes of pulmonary arterial hypertension secondary to congenital portosystemic shunts, Eur J Pediatr, 2021,180(3):929-936.（IF 3.86，Q1）

Li X, Yao R, Tan X, Li N, Ding Y, Li J, Chang G, Chen Y, Ma L, Wang J#, Fu L#, Wang X#.  Molecular and phenotypic spectrum of Noonan syndrome in Chinese patients. Clin Genet,2019, 96(4):290-299. （IF 3.578，Q2）

Chen H, Li X, Liu X, Wang J, Zhang Z, Wu J, Huang M, Guo Y, Li F, Wang X#, Fu L#. Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort, Orphanet J Rare Dis, 2019, 14(1): 29. （IF 3.523，Q2）